全文获取类型
收费全文 | 2904070篇 |
免费 | 221114篇 |
国内免费 | 31997篇 |
专业分类
耳鼻咽喉 | 36933篇 |
儿科学 | 89448篇 |
妇产科学 | 75441篇 |
基础医学 | 395121篇 |
口腔科学 | 75238篇 |
临床医学 | 280897篇 |
内科学 | 552515篇 |
皮肤病学 | 65981篇 |
神经病学 | 227891篇 |
特种医学 | 112663篇 |
外国民族医学 | 960篇 |
外科学 | 414223篇 |
综合类 | 118513篇 |
一般理论 | 993篇 |
预防医学 | 219061篇 |
眼科学 | 66381篇 |
药学 | 225656篇 |
341篇 | |
中国医学 | 29204篇 |
肿瘤学 | 169721篇 |
出版年
2021年 | 31612篇 |
2020年 | 26431篇 |
2019年 | 31160篇 |
2018年 | 39455篇 |
2017年 | 33531篇 |
2016年 | 34663篇 |
2015年 | 44553篇 |
2014年 | 60284篇 |
2013年 | 78183篇 |
2012年 | 106708篇 |
2011年 | 114350篇 |
2010年 | 71758篇 |
2009年 | 65962篇 |
2008年 | 99312篇 |
2007年 | 103821篇 |
2006年 | 104598篇 |
2005年 | 99968篇 |
2004年 | 90544篇 |
2003年 | 87462篇 |
2002年 | 82575篇 |
2001年 | 135586篇 |
2000年 | 138312篇 |
1999年 | 117262篇 |
1998年 | 34572篇 |
1997年 | 30990篇 |
1996年 | 30167篇 |
1995年 | 30815篇 |
1994年 | 27941篇 |
1993年 | 25196篇 |
1992年 | 87145篇 |
1991年 | 83396篇 |
1990年 | 80307篇 |
1989年 | 77361篇 |
1988年 | 70505篇 |
1987年 | 68911篇 |
1986年 | 64292篇 |
1985年 | 61022篇 |
1984年 | 45184篇 |
1983年 | 38052篇 |
1982年 | 22479篇 |
1979年 | 38993篇 |
1978年 | 27421篇 |
1977年 | 23203篇 |
1976年 | 21445篇 |
1975年 | 22779篇 |
1974年 | 26769篇 |
1973年 | 25353篇 |
1972年 | 23761篇 |
1971年 | 21948篇 |
1970年 | 20168篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
S. Liu A. E. Patanwala J. M. Naylor N. Levy R. Knaggs J. A. Stevens B. Bugeja D. Begley K. E. Khor E. Lau R. Allen S. Adie J. Penm 《Anaesthesia》2023,78(10):1237-1248
Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty. 相似文献
2.
Deitelzweig Steve Luo Xuemei Nguyen Jennifer L. Malhotra Deepa Emir Birol Russ Cristina Li Xiaoyan Lee Theodore C. Ferri Mauricio Wiederkehr Danny Reimbaeva Maya Barnes Geoffrey D. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(4):696-696
Journal of Thrombosis and Thrombolysis - 相似文献
3.
目的 探讨集束化干预策略联合闭环管理模式对ICU多重耐药菌感染的防控效果。方法选取2020年1~12月EICU住院患者275例作为对照组,实施常规管理;2021年1~10月EICU住院患者239例作为观察组,在常规管理基础上实施集束化干预策略联合闭环管理。结果实施后,观察组多重耐药菌感染发生率明显低于对照组;患者住院日显著低于对照组,4项护理措施执行率(隔离标识、手卫生、环境消毒、医务人员相关知识知晓)、病原学送检率显著高于对照组(均P<0.05)。结论集束化干预联合信息化闭环管理可有效降低EICU多重耐药菌感染发生率。 相似文献
4.
Huo Jia Fu Lijun Jin Mengyuan Li Zhaoming Zhang Mingzhi 《Investigational new drugs》2022,40(3):537-545
Investigational New Drugs - Background Chemotherapy resistance is a main reason for treatment failure in extranodal NK/T-cell lymphoma (ENKTL). Interleukin-10 (IL-10) is closely related to... 相似文献
5.
Cyclin-Dependent Kinase 4 and 6 Inhibitors as Breast Cancer Therapy: Research Progress and Prospects
Pharmaceutical Chemistry Journal - Cyclin-dependent kinases 4 and 6 (CDK4/6) are the core part of the cell cycle control machinery, which bind to cyclin D to regulate cell G1-S cycle conversion.... 相似文献
6.
7.
8.
Rozhkov V. P. Trifonov M. I. Soroko S. I. 《Neuroscience and behavioral physiology》2022,52(3):383-394
Neuroscience and Behavioral Physiology - We present here results from analysis of the formation of brain bioelectrical activity in children and adolescents living in the northern region of Russia... 相似文献
9.
10.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献